Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Thalidomide. 2026-05-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Nilotinib. 2026-05-10
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V In The Period From 01.01.2025 30.06.2026 - Drug 2026-05-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Combination Valsartan + Indapamide. 2026-05-10
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Buserelin 2026-05-10
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Maraviroc 2026-05-10
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Mercaptopurine 2026-05-10
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V For The Mentioned Active Ingredients With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-05-10
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V For The Mentioned Active Ingredients With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-05-10
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V For The Mentioned Active Ingredients With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-05-10
Whats app